Theramyt Novobiologics' Series A Round

Theramyt Novobiologics raised a round of funding on October 11, 2013.

Theramyt generates unique biologic products combining its strengths in drug designing and platform technologies. The company applies its drug designing and platform technology strengths to deliver the…

Articles about Theramyt Novobiologics' Series A Round: